Clinical Trials Logo

Pulpotomy clinical trials

View clinical trials related to Pulpotomy.

Filter by:

NCT ID: NCT04909827 Completed - Pulpotomy Clinical Trials

3D-printed Endocrowns Versus Prefabricated Zirconia Crowns in Pulpally-treated Primary Molars

Start date: September 1, 2021
Phase: Phase 4
Study type: Interventional

Aim of the study : to compare between 3D printed microfilled hybrid composite endocrowns and prefabricated zirconia crowns for restoring pulpally treated primary molars regarding the following aspects: In Vivo aspects Patient satisfaction *The esthetic, functional and biological performance according to FDI clinical criteria. At 3, 6 and 12 months In Vitro aspects: - Marginal gap. - Fracture resistance. Study methodology: This study is a combined randomized clinical trial and in vitro study .The study will be conducted at the Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Ain Shams University as follows: In vivo comparison of the clinical performance of 3D printed Endocrowns versus prefabricated zirconia crowns regarding esthetic, functional and biological performance according to FDI clinical criteria. In vitro evaluation of the marginal gap and fracture resistance of both types of restorations.

NCT ID: NCT04863222 Recruiting - Pulpotomy Clinical Trials

Clinical and Radiographic Success of MTA vs Biodentine

Start date: November 12, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this prospective study is to compare the clinical and radiographic success of MTA and Biodentine as a medicament in vital pulp therapy in maxillary and mandibular primary molars in a pediatric population. There is limited research currently on Biodentine since it's a novel product. Biodentine is less expensive than MTA and does not cause discoloration like MTA. Biodentine may be an alternative medicament used for vital pulp therapy in primary molars.

NCT ID: NCT04270318 Completed - Pulpotomy Clinical Trials

Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies

Start date: September 2012
Phase: N/A
Study type: Interventional

Aim: The aim of this study was to report the 24-Month radiographical and histological outcome on these previously reported calcium hydroxide (CH) and mineral trioxide aggregate (MTA) pulpotomies using of five percent sodium hypochlorite (NaOCl) as an antibacterial agent to clean the chamber prior to application of the pulpotomy agent. Materials and Methods: 128 primary molars were randomly divided into two main groups according to pulpotomy material (CH/MTA) and into two sub-groups according to selected the antibacterial agent (NaOCl/physiologic saline) used in the pulpotomy procedure. After these procedures, teeth were followed radiographically for 24 months. Thirty-four successfully treated teeth whose successors roots had completed formation of at least two-thirds of their lengths were extracted for histological evaluation. Fisher's-exact test, Pearson's-chi-square test and MannWhitneyU test with Bonferroni correction were used for statistical analysis.

NCT ID: NCT04010929 Completed - Pulpotomy Clinical Trials

Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

The aim of this study was to compare the efficacy of partial pulpotomy treatment using MTA and Er,Cr:YSGG + MTA in permanent immature molar teeth with deep dentin caries. The study was performed in children aged between 6-15 who had at least one deep dentine caries in permanent immature molar tooth. The patients' therapies were completed in Kırıkkale University, Faculty of Dentistry, Department of Pediatric Dentisry. A total of 90 teeth (caries exposed) were included in the study. According to the treatment, the teeth were randomly divided into two groups: 1. MTA group (n=45), 2. Laser+MTA group (n=45). In the MTA group, after removing caries, MTA was applied to the exposed area on the pulp following bleeding control with 5.25% NaOCl. In the same session, the tooth was restored with resin modified glass ionomer cement and composite resin. In the laser+MTA group, the treatment procedures were the same as the MTA group, and before the MTA condensation, Er, Cr: YSGG laser was applied to the exposure area after bleeding control to provide biostimulation. Patients were called for followup appointments at 1, 3, 6 and 12 months after treatment and control radiographs were taken.

NCT ID: NCT03786302 Terminated - Pulpotomy Clinical Trials

Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth

Start date: December 6, 2016
Phase: Phase 2
Study type: Interventional

The aim of this study was to assess clinically, radiographically, and histologically the regenerative ability of Tailored Amorphous Mulioporous (TAMP-BG) bioglass in comparison to Biodentine™ (BD) in pulpotomized primary teeth.

NCT ID: NCT03782714 Completed - Pulpotomy Clinical Trials

Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

This study aimed to assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth. One hundred and six primary molars from 36 children aging five to eight years were included and randomly assigned into two equal groups; LLLT group and FC group. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

NCT ID: NCT03779698 Completed - Dental Caries Clinical Trials

BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars

Start date: May 2014
Phase: Phase 4
Study type: Interventional

The objective of this clinical study was to prospectively compare the clinical and radiographic success rates of BiodentineTM pulpotomies versus formocresol pulpotomies in children vital primary molars. A randomized, split-mouth study design was used with a sample of 37 healthy children aged 4- to 8-year-old. A total of 56 pairs (112 teeth) of carious primary teeth, 1 pair per child, were selected for treatment. One tooth from each pair was randomly assigned to either the BiodentineTM pulpotomy group or the formocresol pulpotomy group. Children were followed-up at 3, 6 and 12 months for clinical evaluation and at 6 and 12 months for radiographic evaluation. Data were collected, tabulated and analyzed using Fisher exact and McNemar tests. The level of significance was set at P < 0.05.

NCT ID: NCT03718676 Completed - Pulpotomy Clinical Trials

Pulpotomy With Various MTA Materials and Ferric Sulphate

Start date: June 2, 2017
Phase: N/A
Study type: Interventional

The aim of this study was to determine clinical and radiographic efficacy of the newly developed OrthoMTA and RetroMTA , compared frequently used ferric sulfate for pulpotomy in primary second molars.

NCT ID: NCT03522051 Completed - Pulpotomy Clinical Trials

Assessment of Pulpotomy Procedure Using NeoMTA Plus in Permanent Teeth With Carious Exposure

PULPOTOMY
Start date: December 1, 2016
Phase: N/A
Study type: Interventional

Many deep carious teeth are treated unnecessarily by root canal therapy, while with using current techniques and advances in compatible dental materials in addition to better understanding of biological response of the dental pulp, many can be treated conservatively via vital pulp therapy procedures.

NCT ID: NCT03395496 Completed - Dental Caries Clinical Trials

Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up

Start date: May 1, 2013
Phase: Early Phase 1
Study type: Interventional

The aim of this study is to compare two pulpotomy medicaments in primary molars clinically.A total of 200 primary molars with deep caries were treated with two different pulpotomy medicaments (Mineral Trioxide Aggregate and BiodentineTM) in this study. The inclusion criteria for tooth selection were no clinical and radiographic evidence of pulp pathology. During 36 months of follow-up at 3-month intervals, clinical and radiographic success and failures were recorded.